Home/Filings/4/0000950170-24-063737
4//SEC Filing

Beskrovnaya Oxana 4

Accession 0000950170-24-063737

CIK 0001818794other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 9:01 PM ET

Size

12.2 KB

Accession

0000950170-24-063737

Insider Transaction Report

Form 4
Period: 2024-05-20
Beskrovnaya Oxana
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-20$1.03/sh+30,426$31,339180,073 total
  • Sale

    Common Stock

    2024-05-20$32.49/sh17,134$556,684162,939 total
  • Sale

    Common Stock

    2024-05-20$34.08/sh1,145$39,022149,647 total
  • Sale

    Common Stock

    2024-05-20$33.51/sh12,147$407,046150,792 total
  • Exercise/Conversion

    Stock option (right to buy)

    2024-05-2030,4260 total
    Exercise: $1.03Exp: 2030-01-05Common Stock (30,426 underlying)
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $32.00 to $33.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $33.01 to $34.01, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $34.02 to $34.16, inclusive.
  • [F5]Includes 130,308 unvested RSUs.
  • [F6]The option was granted on January 6, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on January 27, 2021 and the remaining shares vesting in equal quarterly installments thereafter.

Documents

1 file

Issuer

Dyne Therapeutics, Inc.

CIK 0001818794

Entity typeother

Related Parties

1
  • filerCIK 0001824542

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 9:01 PM ET
Size
12.2 KB